Antibodies Against Cd38 For Treatment Of Multiple Myeloma

Patent No. EP2535355 (titled "Antibodies Against Cd38 For Treatment Of Multiple Myeloma") was filed by Genmab on Mar 23, 2006. The application was issued on Jan 2, 2019.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SECERNAOct 1, 2019SECERNA

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2535355

GENMAB
Application Number
EP12178780A
Filing Date
Mar 23, 2006
Status
Revoked
Jul 3, 2020
Publication Date
Jan 2, 2019